1. Effects of extended-release niacin with laropiprant in high-risk patients;Landray;N Engl J Med,2014
2. Niacin in patients with low HDL cholesterol levels receiving intensive statin therapy;Boden;N Engl J Med,2011
3. FDA Federal Register. 2016. Available at: https://www.federalregister.gov/articles/2016/04/18/2016-08887/abbvie-inc-et-al-withdrawal-of-approval-of-indications-related-to-the-coadministration withstatins?utm_content=previous&utm_medium=PrevNext&utm_source=Article; Accessed April 20, 2016.
4. 2016 AHA CardioBrief: FDA Ends Niacin, Fibrate Combos With Statins and Other Coverage from AHA. Available at: http://cardiobrief.org/2016/04/17/fda-ends-niacin-and-fenofibric-acid-combinations-with-statins/. Accessed April 17, 2016.
5. Beyond LDL-C reduction;Superko;Circulation,1996